Drug Type Small molecule drug |
Synonyms MA9-060, SG3-014 |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), ULK3 inhibitors(Ulk protein kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | US | - | |
Breast Cancer | Discovery | US | - |